Clinical Trial Update: Global, Multicentre, Non Interventional Advagraf Conversion Registry in Kidney Transplant Patients

View source ↗

Summary

Global, multicenter, non-interventional registry evaluating conversion to Advagraf (tacrolimus modified-release) in kidney transplant patients; the study status…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Drugs mentioned

• Advagraf (tacrolimus)

Snippet

Sponsor: Astellas Pharma Europe Ltd. | Conditions: Kidney Transplantation | Status: COMPLETED